Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptides | 17 | 2025 | 656 | 3.830 |
Why?
|
| Nanofibers | 11 | 2024 | 32 | 3.070 |
Why?
|
| Biocompatible Materials | 6 | 2023 | 202 | 1.690 |
Why?
|
| Galectin 3 | 5 | 2023 | 20 | 1.590 |
Why?
|
| Zea mays | 2 | 2024 | 27 | 1.460 |
Why?
|
| Galectin 1 | 3 | 2021 | 6 | 1.330 |
Why?
|
| Carbohydrates | 2 | 2021 | 46 | 1.250 |
Why?
|
| Polysaccharides | 4 | 2022 | 96 | 1.220 |
Why?
|
| Galectins | 2 | 2021 | 11 | 1.170 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2019 | 555 | 1.120 |
Why?
|
| Nanostructures | 3 | 2021 | 89 | 1.110 |
Why?
|
| Protein Conformation, beta-Strand | 9 | 2025 | 17 | 0.960 |
Why?
|
| Freeze Drying | 1 | 2024 | 15 | 0.850 |
Why?
|
| Dendrimers | 1 | 2024 | 11 | 0.850 |
Why?
|
| Extracellular Space | 2 | 2019 | 88 | 0.720 |
Why?
|
| Protein Multimerization | 3 | 2021 | 191 | 0.700 |
Why?
|
| Immunotherapy | 2 | 2018 | 761 | 0.680 |
Why?
|
| Hydrogels | 2 | 2021 | 92 | 0.680 |
Why?
|
| Blood Proteins | 1 | 2021 | 145 | 0.660 |
Why?
|
| Nucleic Acids | 1 | 2021 | 35 | 0.650 |
Why?
|
| Phytochemicals | 1 | 2020 | 6 | 0.630 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 68 | 0.630 |
Why?
|
| Glycogen | 1 | 2020 | 59 | 0.610 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 97 | 0.610 |
Why?
|
| Jurkat Cells | 4 | 2021 | 84 | 0.600 |
Why?
|
| Lipids | 1 | 2021 | 278 | 0.590 |
Why?
|
| Proteins | 2 | 2021 | 803 | 0.570 |
Why?
|
| Luciferases | 1 | 2018 | 129 | 0.570 |
Why?
|
| Acetylglucosamine | 1 | 2018 | 19 | 0.570 |
Why?
|
| Oligopeptides | 2 | 2010 | 191 | 0.570 |
Why?
|
| Enzyme Therapy | 1 | 2018 | 1 | 0.550 |
Why?
|
| Lectins | 1 | 2018 | 83 | 0.550 |
Why?
|
| Plant Extracts | 1 | 2020 | 247 | 0.540 |
Why?
|
| Apoptosis | 2 | 2021 | 1721 | 0.530 |
Why?
|
| Heparin | 3 | 2011 | 181 | 0.490 |
Why?
|
| Glycosylation | 4 | 2022 | 137 | 0.480 |
Why?
|
| Immunomodulation | 1 | 2016 | 63 | 0.470 |
Why?
|
| Macromolecular Substances | 2 | 2025 | 164 | 0.470 |
Why?
|
| Polyethylene Glycols | 4 | 2013 | 373 | 0.460 |
Why?
|
| Protein Binding | 5 | 2022 | 1534 | 0.450 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2011 | 57 | 0.440 |
Why?
|
| Immunologic Factors | 1 | 2016 | 176 | 0.430 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1275 | 0.430 |
Why?
|
| Animals | 17 | 2024 | 28155 | 0.410 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 56 | 0.380 |
Why?
|
| Signal Transduction | 3 | 2021 | 3502 | 0.380 |
Why?
|
| Copper | 2 | 2010 | 79 | 0.370 |
Why?
|
| NIH 3T3 Cells | 2 | 2024 | 111 | 0.360 |
Why?
|
| Antigens | 1 | 2013 | 224 | 0.360 |
Why?
|
| Immobilized Proteins | 1 | 2010 | 15 | 0.320 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 192 | 0.320 |
Why?
|
| Amyloid | 2 | 2021 | 104 | 0.310 |
Why?
|
| Cell Survival | 3 | 2020 | 1004 | 0.310 |
Why?
|
| Peptide Fragments | 1 | 2011 | 470 | 0.300 |
Why?
|
| Focal Adhesions | 1 | 2009 | 66 | 0.290 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 2012 | 0.280 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 139 | 0.280 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2008 | 29 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3435 | 0.260 |
Why?
|
| Stem Cells | 1 | 2010 | 387 | 0.260 |
Why?
|
| Inflammation | 4 | 2023 | 1050 | 0.260 |
Why?
|
| Mice | 7 | 2024 | 12269 | 0.260 |
Why?
|
| Tissue Engineering | 1 | 2008 | 202 | 0.240 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2023 | 61 | 0.240 |
Why?
|
| Humans | 16 | 2023 | 93511 | 0.220 |
Why?
|
| Foreign-Body Reaction | 1 | 2024 | 11 | 0.220 |
Why?
|
| Cryoprotective Agents | 1 | 2024 | 9 | 0.210 |
Why?
|
| Leukocyte Common Antigens | 2 | 2021 | 50 | 0.210 |
Why?
|
| Gels | 1 | 2023 | 51 | 0.200 |
Why?
|
| Galectin 2 | 1 | 2023 | 2 | 0.200 |
Why?
|
| Faculty | 1 | 2023 | 36 | 0.200 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 71 | 0.190 |
Why?
|
| Personnel Selection | 1 | 2023 | 62 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 309 | 0.190 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2021 | 6 | 0.170 |
Why?
|
| Macrophages | 2 | 2024 | 610 | 0.170 |
Why?
|
| Lactose | 1 | 2021 | 26 | 0.170 |
Why?
|
| Alarmins | 1 | 2021 | 6 | 0.170 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 10 | 0.170 |
Why?
|
| Endotoxemia | 1 | 2021 | 18 | 0.170 |
Why?
|
| Rheology | 1 | 2021 | 38 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 256 | 0.160 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 282 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2021 | 88 | 0.160 |
Why?
|
| Cell Death | 1 | 2021 | 253 | 0.160 |
Why?
|
| Hydrodynamics | 1 | 2020 | 20 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 159 | 0.160 |
Why?
|
| Cattle | 2 | 2011 | 397 | 0.160 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 109 | 0.150 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 119 | 0.150 |
Why?
|
| Kinetics | 2 | 2014 | 1492 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 194 | 0.150 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 31 | 0.150 |
Why?
|
| Catalysis | 2 | 2010 | 216 | 0.150 |
Why?
|
| Solubility | 1 | 2020 | 187 | 0.150 |
Why?
|
| Biotechnology | 1 | 2019 | 30 | 0.150 |
Why?
|
| Molecular Structure | 1 | 2020 | 307 | 0.150 |
Why?
|
| Subcutaneous Tissue | 1 | 2018 | 10 | 0.150 |
Why?
|
| Wheat Germ Agglutinins | 1 | 2018 | 15 | 0.140 |
Why?
|
| Plant Lectins | 1 | 2018 | 10 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 392 | 0.140 |
Why?
|
| Transcriptome | 1 | 2024 | 762 | 0.140 |
Why?
|
| Luminescent Measurements | 1 | 2018 | 64 | 0.140 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 131 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2010 | 416 | 0.140 |
Why?
|
| Muscles | 1 | 2018 | 184 | 0.140 |
Why?
|
| Gaucher Disease | 1 | 2018 | 4 | 0.140 |
Why?
|
| alpha-Galactosidase | 1 | 2018 | 5 | 0.140 |
Why?
|
| Glucosylceramidase | 1 | 2018 | 3 | 0.140 |
Why?
|
| Enzymes, Immobilized | 1 | 2018 | 11 | 0.140 |
Why?
|
| Fabry Disease | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 89 | 0.140 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2018 | 11 | 0.140 |
Why?
|
| Asparaginase | 1 | 2018 | 35 | 0.140 |
Why?
|
| Biocatalysis | 1 | 2018 | 55 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2018 | 233 | 0.130 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 331 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2018 | 150 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2018 | 129 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2025 | 304 | 0.130 |
Why?
|
| Protein Conformation | 1 | 2019 | 914 | 0.120 |
Why?
|
| Tuberculosis Vaccines | 1 | 2015 | 19 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 502 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1741 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 353 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 135 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2755 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2019 | 1353 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2010 | 2850 | 0.110 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2014 | 22 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 137 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2021 | 2121 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2014 | 73 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 2014 | 145 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 337 | 0.100 |
Why?
|
| Microspheres | 1 | 2013 | 88 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2015 | 208 | 0.100 |
Why?
|
| Nitrophenols | 1 | 2013 | 12 | 0.100 |
Why?
|
| Vaccines | 1 | 2014 | 84 | 0.100 |
Why?
|
| Organophosphonates | 1 | 2013 | 46 | 0.100 |
Why?
|
| Dithiothreitol | 2 | 2013 | 25 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 173 | 0.090 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2011 | 70 | 0.090 |
Why?
|
| Adsorption | 1 | 2011 | 52 | 0.090 |
Why?
|
| Surface Properties | 1 | 2011 | 126 | 0.090 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 48 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 139 | 0.090 |
Why?
|
| Antibodies | 1 | 2013 | 348 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 131 | 0.080 |
Why?
|
| Acetylene | 1 | 2010 | 2 | 0.080 |
Why?
|
| Azides | 1 | 2010 | 12 | 0.080 |
Why?
|
| Carbodiimides | 1 | 2010 | 6 | 0.080 |
Why?
|
| Amines | 1 | 2010 | 31 | 0.080 |
Why?
|
| Integrins | 1 | 2010 | 79 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1799 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 878 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2010 | 122 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2011 | 274 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 988 | 0.070 |
Why?
|
| Ligands | 1 | 2010 | 476 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 2303 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2022 | 1118 | 0.060 |
Why?
|
| Female | 4 | 2021 | 48698 | 0.060 |
Why?
|
| Rats | 2 | 2023 | 4072 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2025 | 101 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2024 | 39 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 2544 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1621 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2024 | 65 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2023 | 214 | 0.050 |
Why?
|
| Metformin | 1 | 2024 | 125 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 249 | 0.050 |
Why?
|
| Neoplasms | 1 | 2018 | 3169 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 59 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 105 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2023 | 276 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 53 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 18 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 295 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2020 | 29 | 0.040 |
Why?
|
| Polymerization | 1 | 2020 | 36 | 0.040 |
Why?
|
| Static Electricity | 1 | 2020 | 94 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 517 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 301 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1531 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1245 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 730 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 873 | 0.030 |
Why?
|
| Sepsis | 1 | 2021 | 388 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1931 | 0.030 |
Why?
|
| Male | 3 | 2024 | 44553 | 0.030 |
Why?
|
| Emulsions | 1 | 2013 | 18 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2495 | 0.030 |
Why?
|
| Collagenases | 1 | 2013 | 42 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 292 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 123 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7061 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 20430 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 27569 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 27918 | 0.010 |
Why?
|